VAFSEO J Code: J0901

Drug & Product Overview

HCPCS Descriptor Vadadustat, oral, 1 mg (for esrd on dialysis)

HCPCS Added Date January 1, 2025

Manufacturer Akebia Therapeutics

Route of Administration Oral

Generic Status Single-Source; Branded

Dosage Form Tablet, Film Coated

About VAFSEO

Vafseo is a medication aligned to the HCPCS J Code: J0901 for billing, pricing, and reimbursement purposes in the United States. It is an Anti-Anemia drug administered via the oral route and manufactured by Akebia Therapeutics.

Manufacturers, reach out to us to add more information.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
59922-0641-60	Vafseo	Akebia Therapeutics, Inc.	9000	150 MG
59922-0642-60	Vafseo	Akebia Therapeutics, Inc.	18000	300 MG

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

VAFSEO Pricing & Reimbursement

J0901 Private Payer Reimbursement

$0.14 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q4 2026

VAFSEO Medically Unlikely Edits (MUE)

The most billing units of J0901 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.

Practitioner Office & Hospital Outpatient

600 units / day

= 600 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

VAFSEO Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

anemia due to chronic kidney disease

Drug Class

Breast Cancer Resistance Protein Inhibitors [MoA]Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors [MoA]Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC]Organic Anion Transporter 3 Inhibitors [MoA]

Frequently Asked Questions

Is there an available VAFSEO billing and coding guide?

Billing and coding information for VAFSEO can be found through Akebia Therapeutics. Visit Here →

What are the available VAFSEO patient assistance programs?

VAFSEO patient assistance information can be found through Akebia Therapeutics. Visit Here →

Where can I find VAFSEO prescribing information?

VAFSEO prescribing information can be found at the link below. Visit Here →

Where can I find VAFSEO side effect information?

VAFSEO side effect information can be found through MedlinePlus at the link below.

Does billing VAFSEO require JZ/JW wastage modifiers?

CMS does not include VAFSEO (J0901) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J0901. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.